Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study
- PDF / 470,151 Bytes
- 4 Pages / 595.276 x 790.866 pts Page_size
- 67 Downloads / 194 Views
Evaluation of a rapid turn‑over, fully‑automated ADAMTS13 activity assay: a method comparison study Jan Stratmann1,3 · Josephine‑Nana Ward1,2 · Wolfgang Miesbach1,2
© The Author(s) 2020
Abstract Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy caused by severely reduced activity of the von-Willebrand factor-cleaving protease ADAMTS13, mainly caused by anti-ADAMTS-13 antibodies. Although several test systems for ADAMTS13 measurement exist, long turn-around times hamper the usability in daily practice. We performed a method comparison study for two commercially available ADAMTS13 assays and evaluated the agreement between the fully-automated rapid turn-over HemosIL AcuStar ADAMTS13 Activity assay and the manually performed TECHNOZYM ADAMTS-13 Activity assay. Twenty-four paired test samples derived from 10 consecutively recruited patients (n = 8, acquired TTP; n = 1, atypical hemolytic uremic syndrome; n = 1, control), of which nine test samples were collected in case of clinically apparent TTP and 13 samples were collected from TTP patients in clinical remission were included. Overall correlation between the TECHNOZYM and AcuStar assay was good with a Pearson R of 0.93 (p or
Data Loading...
